Furthermore, the co-administration of these two drugs resulted in a significant increase in apoptosis of leukemia cell lines, including Jurkat (Figure 5d), MOLM13 (Figure 5e), and K562 (Figure 5f), as evidenced by a substantial rise in the proportion of apoptotic cells and the upregulated apoptotic protein, cleaved caspase 3 (Figure 5g). The gene discussed is CASP3; the disease is leukemia.